• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Crit Care Resusc. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy

tetano

Editor, Senior Moderator
Crit Care Resusc. 2020 Apr 23. [Epub ahead of print]
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy.


Zangrillo A[SUP]1[/SUP], Beretta L[SUP]1[/SUP], Scandroglio AM[SUP]1[/SUP], Monti G[SUP]1[/SUP], Fominskiy E[SUP]1[/SUP], Colombo S[SUP]1[/SUP], Morselli F[SUP]1[/SUP], Belletti A[SUP]1[/SUP], Silvani P[SUP]1[/SUP], Crivellari M[SUP]1[/SUP], Monaco F[SUP]1[/SUP], Azzolini ML[SUP]1[/SUP], Reineke R[SUP]1[/SUP], Nardelli P[SUP]1[/SUP], Sartorelli M[SUP]1[/SUP], Votta CD[SUP]1[/SUP], Ruggeri A[SUP]1[/SUP], Ciceri F[SUP]2[/SUP], De Cobelli F[SUP]2[/SUP], Tresoldi M[SUP]3[/SUP], Dagna L[SUP]2[/SUP], Rovere-Querini P[SUP]2[/SUP], Serpa Neto A[SUP]4[/SUP], Bellomo R[SUP]4[/SUP], Landoni G[SUP]5[/SUP]; COVID-BioB Study Group.

Author information




Abstract

Objective:

Describe characteristics, daily care and outcomes of patients with coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS).
Design:

Case series of 73 patients.
Setting:

Large tertiary hospital in Milan.
Participants:

Mechanically ventilated patients with confirmed COVID-19 admitted to the intensive care unit (ICU) between 20 February and 2 April 2020.
Main outcome measures:

Demographic and daily clinical data were collected to identify predictors of early mortality.
Results:

Of the 73 patients included in the study, most were male (83.6%), the median age was 61 years (interquartile range [IQR], 54-69 years), and hypertension affected 52.9% of patients. Lymphocytopenia (median, 0.77 x 10[SUP]3[/SUP] per mm[SUP]3[/SUP] ; IQR, 0.58-1.00 x 10[SUP]3[/SUP] per mm[SUP]3[/SUP]), hyperinflammation with C-reactive protein (median, 184.5 mg/dL; IQR, 108.2-269.1 mg/dL) and pro-coagulant status with D-dimer (median, 10.1 μg/m; IQR, 5.0-23.8 μg/m) were present. Median tidal volume was 6.7 mL/kg (IQR, 6.0-7.5 mL/kg), and median positive end-expiratory pressure was 12 cmH[SUB]2[/SUB]O (IQR, 10-14 cmH[SUB]2[/SUB]O). In the first 3 days, prone positioning (12-16 h) was used in 63.8% of patients and extracorporeal membrane oxygenation in five patients (6.8%). After a median follow-up of 19.0 days (IQR, 15.0-27.0 days), 17 patients (23.3%) had died, 23 (31.5%) had been discharged from the ICU, and 33 (45.2%) were receiving invasive mechanical ventilation in the ICU. Older age (odds ratio [OR], 1.12; 95% CI, 1.04-1.22; P = 0.004) and hypertension (OR, 6.15; 95% CI, 1.75-29.11; P = 0.009) were associated with mortality, while early improvement in arterial partial pressure of oxygen (PaO[SUB]2[/SUB]) to fraction of inspired oxygen (FiO[SUB]2[/SUB]) ratio was associated with being discharged alive from the ICU (P = 0.002 for interaction).
Conclusions:

Despite multiple advanced critical care interventions, COVID-19 ARDS was associated with prolonged ventilation and high short term mortality. Older age and pre-admission hypertension were key mortality risk factors.
Trial registration:

ClinicalTrials.gov identifier: NCT04318366.



KEYWORDS:

Anesthesia and intensive care; COVID-19; ICU; SARS-CoV-2


PMID:32353223
 
Back
Top Bottom